Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M CONDON

Showing results (141-150 of 169) with videos related to

Pageof 17
Sort By:
Cell Death Discovery|February 3, 2017
Bivalent IAP antagonists, but not monovalent IAP antagonists, inhibit TNF-mediated NF-<i>κ</i>B signaling by degrading TRAF2-associated cIAP1 in cancer cellsY Mitsuuchi, C A Benetatos, Y Deng, et al.
Angewandte Chemie (International Ed. in English)|May 2, 2018
Nanomolar Inhibitors for Two Distinct Biological Target Families from a Single Synthetic Sequence: A Next Step in Combinatorial Library Design?Christopher J Burns, Robert D Groneberg, Joseph M Salvino, et al.
Behavioural Brain Research|April 28, 2021
Rapamycin, but not minocycline, significantly alters ultrasonic vocalization behavior in C57BL/6J pups in a flurothyl seizure modelSamantha L Hodges, Paige D Womble, Eliesse M Kwok, et al.
Biochemistry|November 22, 2017
Dynamic Glycosylation Governs the Vertebrate COPII Protein Trafficking PathwayNathan J Cox, Gokhan Unlu, Brittany J Bisnett, et al.
Bioorganic & Medicinal Chemistry Letters|May 10, 2011
The discovery and structure-activity relationships of pyrano[3,4-b]indole-based inhibitors of hepatitis C virus NS5B polymeraseRandy W Jackson, Matthew G LaPorte, Torsten Herbertz, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 9, 2019
Does recall period matter? Comparing PROMIS<sup>®</sup> physical function with no recall, 24-hr recall, and 7-day recallDavid M Condon, Robert Chapman, Sara Shaunfield, et al.
The Journal of Cell Biology|July 9, 2008
TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalphaJames E Vince, Diep Chau, Bernard Callus, et al.
Journal of Medicinal Chemistry|March 3, 1999
Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an (arylsulfonyl)hydroxamic acid templateR D Groneberg, C J Burns, M M Morrissette, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2019
PROMIS<sup>®</sup> Adult Health Profiles: Efficient Short-Form Measures of Seven Health DomainsDavid Cella, Seung W Choi, David M Condon, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2010
The discovery and structure-activity relationships of pyrano[3,4-b]indole based inhibitors of hepatitis C virus NS5B polymeraseMatthew G LaPorte, Tandy L Draper, Lori E Miller, et al.
Pageof 17

Showing results (141-150 of 169) with videos related to

Sort By:
Pageof 17
Cell Death Discovery|February 3, 2017
Bivalent IAP antagonists, but not monovalent IAP antagonists, inhibit TNF-mediated NF-<i>κ</i>B signaling by degrading TRAF2-associated cIAP1 in cancer cellsY Mitsuuchi, C A Benetatos, Y Deng, et al.
Angewandte Chemie (International Ed. in English)|May 2, 2018
Nanomolar Inhibitors for Two Distinct Biological Target Families from a Single Synthetic Sequence: A Next Step in Combinatorial Library Design?Christopher J Burns, Robert D Groneberg, Joseph M Salvino, et al.
Behavioural Brain Research|April 28, 2021
Rapamycin, but not minocycline, significantly alters ultrasonic vocalization behavior in C57BL/6J pups in a flurothyl seizure modelSamantha L Hodges, Paige D Womble, Eliesse M Kwok, et al.
Biochemistry|November 22, 2017
Dynamic Glycosylation Governs the Vertebrate COPII Protein Trafficking PathwayNathan J Cox, Gokhan Unlu, Brittany J Bisnett, et al.
Bioorganic & Medicinal Chemistry Letters|May 10, 2011
The discovery and structure-activity relationships of pyrano[3,4-b]indole-based inhibitors of hepatitis C virus NS5B polymeraseRandy W Jackson, Matthew G LaPorte, Torsten Herbertz, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 9, 2019
Does recall period matter? Comparing PROMIS<sup>®</sup> physical function with no recall, 24-hr recall, and 7-day recallDavid M Condon, Robert Chapman, Sara Shaunfield, et al.
The Journal of Cell Biology|July 9, 2008
TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalphaJames E Vince, Diep Chau, Bernard Callus, et al.
Journal of Medicinal Chemistry|March 3, 1999
Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an (arylsulfonyl)hydroxamic acid templateR D Groneberg, C J Burns, M M Morrissette, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2019
PROMIS<sup>®</sup> Adult Health Profiles: Efficient Short-Form Measures of Seven Health DomainsDavid Cella, Seung W Choi, David M Condon, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2010
The discovery and structure-activity relationships of pyrano[3,4-b]indole based inhibitors of hepatitis C virus NS5B polymeraseMatthew G LaPorte, Tandy L Draper, Lori E Miller, et al.
Pageof 17